This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background Hypertrophic cardiomyopathy (HCM) is commonly associated with atrialfibrillation (AF), but its impact on outcomes in real-world practice is uncertain. The aim of the study was to evaluate the clinical profile and prognosis of patients with HCM and AF. Methods Overall, 1739 adult patients with HCM (40.9% of the patients.
People with conditions or habits such as high blood pressure, an irregular heartbeat called atrialfibrillation, or smoking, not only have a higher risk of stroke, they may also have more severe strokes than people without these riskfactors.
Pulsed-field ablation (PFA) offers notable advantages in atrialfibrillation (AF) ablation by selectively targeting cardiomyocytes via an irreversible electroporation mechanism, thereby minimizing damage to surrounding tissues.
Background Atrialfibrillation (AF) and acute myocardial infarction (AMI) share riskfactors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both conditions. Whether the risks of outcomes differ according to temporal order of AF and AMI is unclear.
An international consensus statement on how to treat atrialfibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
The term ‘epidemic’ is increasingly used to describe the rising global prevalence of atrialfibrillation (AF). Accordingly, the management of AF has shifted towards a holistic and integrated approach, targeting comorbidities and riskfactors, itself associated with improved outcomes. 2 Before the.
2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib. Global epidemiology of atrialfibrillation: An increasing epidemic and public health challenge. Epidemiology of AtrialFibrillation in the 21st Century. Int J Stroke. 2021 Feb;16(2):217-221. doi: 10.1177/1747493019897870.
About AtrialFibrillation and Pulsed Field Ablation AF is one of the most common and undertreated heart rhythm disorders, affecting more than 60 million people worldwide3. 4-7 Current ablation technologies rely on thermal effects to target cardiac tissue and risk damage to additional collateral structures in the heart.
Patients who present with persistent atrialfibrillation at diagnosis are more likely to have certain riskfactors as compared with patients with occasional atrialfibrillation (AFib).
During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrialfibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.
When we explore the three traditional cardiometabolic riskfactors (obesity, type 2 diabetes, and dyslipidemia) and the emerging cardiometabolic riskfactor of non-alcoholic fatty liver disease, we unearth a complex interplay of societal, biological, genetic, and environmental factors. . #1
To investigate standardized incidence of atrialfibrillation (AF) in individuals with type 1 diabetes (T1DMM) compared with matched controls from the general population. Additionally, to examine optimal levels.
to 6.4%), atrialfibrillation (1.7% Most adverse trends are projected to be worse among people identifying as American Indian/Alaska Native or multiracial, Black, or Hispanic.CONCLUSIONS:The prevalence of many cardiovascular riskfactors and most established diseases will increase over the next 30 years.
The increasing prevalence of atrialfibrillation (AF) in adults with congenital heart disease raises significant questions regarding its management. Journal of the American Heart Association, Ahead of Print. Emerging imaging modalities and ablation techniques might have a role to play.
People with conditions or habits such as high blood pressure, an irregular heartbeat called atrialfibrillation, or smoking, not only have a higher risk of stroke, they may also have more severe strokes than people without these riskfactors, according to a study published in the journal Neurology.
Recommendations from the “2014 AHA/ACC/HRS Guideline for the Management of Patients With AtrialFibrillation” and the “2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With AtrialFibrillation” have been updated with new evidence to guide clinicians.
BackgroundClinical and genetic predispositions are significant in predicting atrialfibrillation (AF); however, their role in patients with hypertrophic cardiomyopathy (HCM) remains unclear. Journal of the American Heart Association, Ahead of Print.
This study aimed to identify the riskfactors for postoperative atrialfibrillation in patients with valvular atrialfibrillation, and establish predictive models of atrialfibrillation recurrence.
Atrialfibrillation (AF) is the most common arrhythmia in the U.S., Black Americans are less prone to develop AF than White Americans, but they display a higher burden of modifiable riskfactors for cardiovascular disease and higher rates of ischemic stroke.
The authors reported that the regular use of fish oil supplements might be a riskfactor for atrialfibrillation among general population. When used as primary prevention in healthy persons, fish oil supplements were associated with an increased risk of atrialfibrillation.
Atrialfibrillation (AF) is the most common sustained cardiac dysrhythmia encountered in practice. In contrast, beyond riskfactor optimisation, the ideal management of subclinical or device-detected AF remains undefined. For clinically apparent AF, the investigations and management are relatively well established.
16, 2025 Primary results from the DEFINE AFib clinical study show the Medtronic LINQ family of insertable cardiac monitors (ICM), paired with a novel algorithm, were able to detect atrialfibrillation episodes and properly risk stratify patients as high risk prior to an AF-related healthcare utilization 80% of the time.
Atrialfibrillation (AF) is the most common sustained cardiac rhythm disorder, affecting an estimated 43 million people globally. Atrialfibrillation (AF) is the most common sustained cardiac rhythm disorder, affecting an estimated 43 million people globally.
Atrialfibrillation is the most prevalent sustained cardiac arrhythmia and an important riskfactor for ischemic stroke resulting in a fivefold increased stroke risk. The clinical utility of polygenic risk scores for ischemic stroke prediction among atrialfibrillation patients has not yet been established.
Research Highlights: A clinical trial with adults who have atrialfibrillation (AFib) and an implanted heart device found similar improvements to the amount of time they experienced arrhythmia regardless of whether they received standard care.
Cox proportional hazards models adjusting for established riskfactors were used to associate BMP10 levels with clinical outcomes, including all-cause mortality and HF hospitalisation.
Atrialfibrillation (AF) is the most common heart rhythm disorder in clinical practice. It worsens the quality of life of patients, leads to an increase in the mortality rate because of its association with a high risk of thromboembolic complications.
Rate vs Rhythm Control in AtrialFibrillation Rate vs rhythm control as a management strategy in atrialfibrillation has been a long standing topic for debate. EAST-AFNET 4 trial had 2789 patients with early atrialfibrillation and cardiovascular conditions [8]. years of follow up per patient.
Background The relationship between combined genetic predisposition and lifestyle and the risk of incident atrialfibrillation (AF) is unclear. Therefore, we aimed to assess a possible interaction between lifestyle and genetics on AF risk.
Background Postoperative atrialfibrillation (POAF) is a frequent complication that may increase morbidity and mortality risk following cardiac surgery. Recent studies have reported associations between elevated SII and increased POAF risk; however, significant heterogeneity exists regarding its predictive efficacy.
The influence of hemodynamic parameters on the recurrence of atrialfibrillation (AF) following catheter ablation is not well known, and it remains unclear whether a nomogram combining riskfactors and hemodynamic parameters improves prediction accuracy.
A preoperative history of atrialfibrillation in patients receiving durable left ventricular assist device (LVAD) implantation has been identified as a riskfactor for postoperative morbidity and mortality.
Introduction: Post-operative atrialfibrillation (POAF) is a common complication of cardiac surgery (CS). Clinical riskfactor models have been developed for POAF but they are not highly accurate and do not include genetic factors.
Atrialfibrillation often shortened to AFib is an irregular and often rapid heart rhythm that can lead to serious health complications. Maintain a Healthy Weight – Excess weight is a major riskfactor for AFib. The post How to Prevent an AtrialFibrillation Attack appeared first on AMS Cardiology.
We are diagnosing atrialfibrillation (AF) more often that at any time in history. This is driven by the aging of our populations, the growing prevalence of AF riskfactors and by the proliferation of longer-term electrocardiographic monitoring, including patient-facing technologies 1,2.
ABSTRACT Background Aging of the population has resulted in more patients living with atrialfibrillation (AF) and age-related macular degeneration (AMD). There is also an increase in age-related macular degeneration (AMD), which shares many pathophysiologic riskfactors of AF.
Abstract Background Postoperative atrialfibrillation (POAF) is the most frequent cardiac arrhythmia following cardiac operations. It has been associated with an increased risk of postoperative cerebrovascular complications, morbidity and mortality. At 1250-day follow-up, While the incidence of POAF was 2.9%
Background Heart failure (HF) is not included in atrialfibrillation (AF) bleeding risk prediction scores, reflecting uncertainty regarding its importance as a riskfactor for major haemorrhage.
Asthma is a known riskfactor for atrialfibrillation (AF), the most common sustained arrhythmia. While radiofrequency catheter ablation is effective in treating AF, the impact of asthma and its severity on ablation outcomes has not been previously explored.
The prevalence of atrialfibrillation (AF) is increasing in the U.S., Alcohol is a well-established modifiable riskfactor for recurrence among patients with paroxysmal AF, among whom even a single drink of alcohol doubles the risk of AF episodes and abstention causally reduces AF burden.2
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillation Ablation [abstract].
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
88 
Let's personalize your content